Why Did Stanley Druckenmiller Buy Natera Stock?
Stanley Druckenmiller is among the most astute stock pickers in the world and often ahead of broader market consensus. That may be attributable to his view …
Genetic Technologies Ltd
Will Acadia Pharmaceuticals Stock Recover?
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is at the forefront of neuroscience developing therapies for central nervous system conditions. The company primarily …
Why Did Cathie Wood Buy Invitae Stock?
Invitae Corporation (NYSE:NVTA) made the cut into Cathie Wood’s portfolio but does this high-risk, high-reward genetic testing play deserve a place in …
Best Stocks to Invest $50,000 Right Now
Uncovering the right stocks to channel your hard-earned resources into can be an exciting and daunting challenge. However, if you have $50,000 to hand, you …
Obesity Epidemic: Best Stocks to Invest In
According to an article published in The New England Journal of Medicine, the United States is only a few years away from witnessing a massive surge in the …
Is Vertex Stock Undervalued?
Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX) stock has been on an incredible run over the past few years. The biotech company’s impressive growth is due to its …
Why Did CureVac Stock Go Up?
CureVac is a German biotechnology company that specializes in the development of messenger RNA (mRNA) vaccines and therapies. CureVac has been focused on using …
Will Pfizer Go Up?
Will Pfizer Go Up? The COVID crisis of 2020 turned out to be a significant growth driver for the multinational drug company Pfizer and its German counterpart, …
Pfizer vs Moderna Legal Battle: Who Wins?
Pfizer vs Moderna Legal Battle: American biotechnology firm Moderna emerged as one of the most widely-recognized success stories of the coronavirus era. The …
Regeneron Pharma Stock Forecast
Regeneron Pharma Stock Forecast: Despite centuries of progress in medicine – and a collection of high-impact advances in the past 50 years – …
2 Biotech Stocks To Hold For 10 Years
The biotech sector suffered a mixed run of fortunes lately. While some industry stalwarts, like Pfizer, Stryker, and Roche, are down double digits this year, …